Berry Plastics appoints president of consumer packaging

Berry Plastics appointed Jean-Marc Galvez as president of its consumer packaging division

Berry Plastics Group, Inc. appointed Jean-Marc Galvez as president of its consumer packaging division. Galvez currently serves as president for the company’s health, hygiene, and specialties division in the Europe, Middle East, India, and Africa regions.

Galvez will assume his new role Jan. 1, 2017. He succeeds Tom Salmon, who was appointed as Berry Plastics’ President and chief operating officer, on Oct. 3, 2016.

“I look forward to working closely with Jean-Marc as Berry continues to build upon its strong North American Consumer Packaging business and implements strategic initiatives to increase the business’s global presence,” Salmon says.

Galvez joined AVINTIV, Charlotte, NC, which Berry acquired in 2015, in July 2011 as vice president of sales, marketing, and product development for Europe. Prior to joining the company, he was the global commercial general manager at Merquinsa from 2002-2011. He also held various global general manager and commercial roles of increasing responsibility at Monsanto in Belgium, and Dow Chemical in Switzerland. Galvez holds a master’s and bachelor’s degree in chemical engineering from Ecole Nationale Superieure de Chimie in Monpellier, France.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?